OBERON
An integrative strategy of testing systems for identification of EDs related to metabolic disorders
- Duration
- 01/01/2019 - 31/12/2023
- Coordinator
- Karine Audouze
- Funded by
- European Union’s Horizon 2020
- Website
- https://oberon-4eu.com
Exposure to chemical substances that can produce endocrine disrupting effects represents one of the most critical public health threats nowadays. In line with the regulatory framework implemented within the European Union to reduce the levels of endocrine disruptors (EDs) for consumers, new and effective methods for ED testing are needed.
The OBERON project will build an integrated approach for testing and assessment (IATA) to detect endocrine disruptors-related metabolic disorders by developing, improving and validating a battery of test systems.
Total funding
€ 5,978,762
Our Team
Coordinator
- Karine Audouze
ISGlobal Team
-
Maribel Casas Assistant Research Professor - Nuria Güil Predoctoral Researcher
-
Lea Maitre Postdoctoral Researcher -
Martine Vrijheid Head of the Childhood and Environment Programme, Research Professor -
Charline Warembourg Research Collaborator
Other projects
See Past ProjectsINMA - Environment and Childhood Project
Born in Bradford
EGG/EAGLE
Early Genetics Growth/Early Genetics and Lifecourse Epidemiology
HBM4EU
APACHE
Air Pollution, Autism spectrum disorders, and brain imaging in CHildren amongst Europe
ELFES
LIFECYCLE
Early-life stressors and LifeCycle health
STOP - Childhood Obesity
Science and Technology in childhood Obesity Policy
BiSC (Barcelona Life Study Cohort)
HERA
Integrating Environment and Health Research: a Vision for the EU
ATHLETE
Advancing Tools for Human Early Lifecourse Exposome Research and Translation
MOOD-COVID
Pre- and post-natal Maternal mental health and newbOrn neurOdevelopment during the COVID-19 panDemic
EUCAN-Connect
A federated FAIR platform enabling large-scale analysis of high-value cohort data connecting Europe and Canada in personalized health